Search Results Search Sort by RelevanceMost Recent Personal Narrative Jul 2021 Depression’s Problem With Men Nathan Swetlitz While men are diagnosed with depression at half the rate of women, they die by suicide 3 to 4 times as frequently. AMA J Ethics. 2021;23(7):E586-589. doi: 10.1001/amajethics.2021.586. Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310. Health Law Oct 2003 In Defense of Absolute Confidentiality Kenneth Kipnis, PhD Virtual Mentor. 2003;5(10):449-454. doi: 10.1001/virtualmentor.2003.5.10.hlaw2-0310. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Case and Commentary Jul 2017 Should Dementia Be Accepted as a Disability to Help Restore Hope during Cognitive Decline? Nathaniel M. Robbins, MD and James L. Bernat, MD Patients with dementia need social supports and opportunities and acceptance of their disability in order to feel hopeful despite their functional decline. AMA J Ethics. 2017;19(7):649-655. doi: 10.1001/journalofethics.2017.19.7.ecas2-1707. Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Personal Narrative Jul 2021 Depression’s Problem With Men Nathan Swetlitz While men are diagnosed with depression at half the rate of women, they die by suicide 3 to 4 times as frequently. AMA J Ethics. 2021;23(7):E586-589. doi: 10.1001/amajethics.2021.586.
Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310.
Health Law Oct 2003 In Defense of Absolute Confidentiality Kenneth Kipnis, PhD Virtual Mentor. 2003;5(10):449-454. doi: 10.1001/virtualmentor.2003.5.10.hlaw2-0310.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Case and Commentary Jul 2017 Should Dementia Be Accepted as a Disability to Help Restore Hope during Cognitive Decline? Nathaniel M. Robbins, MD and James L. Bernat, MD Patients with dementia need social supports and opportunities and acceptance of their disability in order to feel hopeful despite their functional decline. AMA J Ethics. 2017;19(7):649-655. doi: 10.1001/journalofethics.2017.19.7.ecas2-1707.
Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612.